<h1>Legal risks for AI-driven 5G telesurgery robot: regulatory approval, data protection, cross-border licensure, liability, and cybersecurity</h1> A medical device company announced a next-generation soft-tissue surgical robot integrating AI-driven 3D mapping, 5G-enabled telesurgery, and remote training, raising legal considerations including device regulatory approval and compliance with medical device standards, AI transparency and validation, cross-border licensure for surgeons, telemedicine and data-protection obligations for patient data transmitted over networks, and cybersecurity risk management for remote operative control. Potential product liability, informed-consent practices for remote procedures, export controls and import regulations, and contractual allocation of risk with healthcare providers and telecom partners will be central to commercialization and deployment.